COALITION II Covid-19 Brazil (Furtado), 2020 NCT04321278
azithromycin vs. standard of care
COVID-19 severe or critically
Duke University azithromycin, 2020 NCT04335552
azithromycin vs. standard of care
COVID-19 severe or critically
Karolyi, 2020
chloroquine and derivatives vs. lopinavir/ritonavir
COVID-19 severe or critically
Duke university (Hydroxychloroquine), 2020 NCT04335552
chloroquine and derivatives vs. standard of care
COVID-19 severe or critically
Kocayigit H, 2020
favipiravir vs. lopinavir/ritonavir
COVID-19 severe or critically
Yu, 2020
hydroxychloroquine vs. control
COVID-19 severe or critically
HYDRA, 2020 NCT04315896
hydroxychloroquine vs. placebo
COVID-19 severe or critically
HYDRA (Hernandez-Cardenas), 2021 NCT04315896
hydroxychloroquine vs. placebo
COVID-19 severe or critically
Sarhan, 2022 NCT04779047
hydroxychloroquine vs. remdesivir
COVID-19 severe or critically
REMAP-CAP-HCQ, 2020 NCT02735707
hydroxychloroquine vs. standard of care
COVID-19 severe or critically
Mahevas, 2020
hydroxychloroquine vs. standard of care
COVID-19 severe or critically
Sarhan, 2022 NCT04779047
hydroxychloroquine vs. tocilizumab
COVID-19 severe or critically
AZIQUINE-ICU (A plus HCQ), 0 NCT04339816
hydroxychloroquine plus macrolides vs. placebo
COVID-19 severe or critically
Huang, 2020
hydroxychloroquine plus macrolides vs. standard of care
COVID-19 severe or critically
Galan, 2021 RBR-8h7q82
ivermectin vs. chloroquine
COVID-19 severe or critically
Galan, 2021 RBR-8h7q82
ivermectin vs. hydroxychloroquine
COVID-19 severe or critically
Niaee (vs placebo), 2020 IRCT20200408046987N1
ivermectin vs. placebo
COVID-19 severe or critically
Okumuş, 2020 NCT04646109
ivermectin vs. standard of care
COVID-19 severe or critically
Camprubi, 2020
ivermectin vs. standard of care
COVID-19 severe or critically
NCT04347239, 0 NCT04347239
leronlimab vs. placebo
COVID-19 severe or critically
NCT00578825, 0 NCT00578825
lopinavir / ritonavir plus ribavirin vs. placebo
COVID-19 severe or critically
Cao, 2020 ChiCTR2000029308
lopinavir/ritonavir vs. standard of care
COVID-19 severe or critically
REMAP-CAP (lopinavir/ritonavir only), 2020 NCT02735707
lopinavir/ritonavir vs. standard of care
COVID-19 severe or critically
REMAP-CAP (lopinavir/ritonavir plus hydroxychloroquine), 2020 NCT02735707
Lopinavir/ritonavir plus hydroxychloroquine vs. standard of care
COVID-19 severe or critically
CAP-China (Wang et al.), 2020 NCT04257656
remdesivir vs. placebo
COVID-19 severe or critically
Eslami, 2020 IRCT20200324046850N2
sofosbuvir and daclatasvir vs. ribavirin
COVID-19 severe or critically